No. |
Chromosome Location |
Chromatin state |
Cell line |
Tissue |
1 |
chr1:75598800-75603200 |
Bivalent/Poised TSS |
ES-I3 Cell Line |
embryonic stem cell
|
2 |
chr1:75598800-75603600 |
Active TSS |
hESC Derived CD56+ Mesoderm Cultured Cells |
ES cell derived
|
3 |
chr1:75599600-75603400 |
Bivalent/Poised TSS |
iPS-20b Cell Line |
embryonic stem cell
|
4 |
chr1:75600200-75603200 |
Bivalent Enhancer |
Primary B cells from peripheral blood |
blood
|
5 |
chr1:75600600-75603800 |
Bivalent/Poised TSS |
HUES64 Cell Line |
embryonic stem cell
|
6 |
chr1:75601400-75603200 |
Bivalent Enhancer |
Breast Myoepithelial Primary Cells |
Breast
|
7 |
chr1:75601400-75603200 |
Bivalent Enhancer |
Fetal Muscle Leg |
muscle
|
8 |
chr1:75601400-75603200 |
Bivalent Enhancer |
Lung |
lung
|
9 |
chr1:75601600-75603200 |
Bivalent Enhancer |
Fetal Adrenal Gland |
Adrenal Gland
|
10 |
chr1:75602400-75603200 |
Bivalent Enhancer |
Primary hematopoietic stem cells G-CSF-mobilized Male |
--
|
11 |
chr1:75602400-75603200 |
Bivalent Enhancer |
Foreskin Fibroblast Primary Cells skin01 |
Skin
|
12 |
chr1:75602400-75603200 |
Bivalent Enhancer |
Foreskin Fibroblast Primary Cells skin02 |
Skin
|
13 |
chr1:75602400-75603200 |
Bivalent Enhancer |
Fetal Muscle Trunk |
muscle
|
14 |
chr1:75602600-75604800 |
Weak transcription |
Right Atrium |
heart
|
15 |
chr1:75602800-75603200 |
Flanking Bivalent TSS/Enh |
iPS DF 19.11 Cell Line |
embryonic stem cell
|
16 |
chr1:75602800-75603400 |
Flanking Bivalent TSS/Enh |
H1 Cell Line |
embryonic stem cell
|
17 |
chr1:75602800-75603400 |
Bivalent/Poised TSS |
H9 Cell Line |
embryonic stem cell
|
18 |
chr1:75602800-75603400 |
Flanking Bivalent TSS/Enh |
HUES48 Cell Line |
embryonic stem cell
|
19 |
chr1:75602800-75603400 |
Flanking Bivalent TSS/Enh |
HUES6 Cell Line |
embryonic stem cell
|
20 |
chr1:75602800-75603400 |
Flanking Bivalent TSS/Enh |
iPS-15b Cell Line |
embryonic stem cell
|
21 |
chr1:75602800-75603400 |
Bivalent Enhancer |
Adipose Derived Mesenchymal Stem Cell Cultured Cells |
ES cell derived
|
22 |
chr1:75603000-75603200 |
Bivalent Enhancer |
H1 BMP4 Derived Mesendoderm Cultured Cells |
ES cell derived
|
23 |
chr1:75603000-75603200 |
Flanking Bivalent TSS/Enh |
hESC Derived CD184+ Endoderm Cultured Cells |
ES cell derived
|
24 |
chr1:75603000-75603200 |
Flanking Bivalent TSS/Enh |
hESC Derived CD56+ Ectoderm Cultured Cells |
ES cell derived
|
25 |
chr1:75603000-75603200 |
Flanking Bivalent TSS/Enh |
iPS DF 6.9 Cell Line |
embryonic stem cell
|
26 |
chr1:75603000-75603200 |
Flanking Bivalent TSS/Enh |
Mesenchymal Stem Cell Derived Adipocyte Cultured Cells |
ES cell derived
|
27 |
chr1:75603000-75603200 |
Bivalent Enhancer |
Adipose Nuclei |
Adipose
|
28 |
chr1:75603000-75603400 |
Bivalent Enhancer |
H1 Derived Mesenchymal Stem Cells |
ES cell derived
|
29 |
chr1:75603000-75603400 |
Flanking Bivalent TSS/Enh |
iPS-18 Cell Line |
embryonic stem cell
|
30 |
chr1:75603000-75603400 |
Flanking Bivalent TSS/Enh |
ES-UCSF4 Cell Line |
embryonic stem cell
|